Press Releases WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Delayed OTC Markets Other stock markets 11:16:54 28/05/2024 pm IST			5-day change	1st Jan Change
2.95 ^USD	-6.65%		-11.54%	-60.40%

27/05	China stocks rise as industrial profits grow; energy, semiconductor shares lead gains	RE
17/05	Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment	30/04	PU
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024	16/04	AQ
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories	03/04	AQ
WuXi Biologics Reports Solid 2023 Annual Results	27/03	AQ
WuXi Biologics Named to CDP 'A List' for Water Security	25/03	AQ
WuXi Biologics Cayman : Breaks Ground on CRDMO Center in Singapore	19/03	PU
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment	06/03	AQ
WuXi Biologics Ireland Site Receives Three ISO Certifications	04/03	AQ
WuXi Biologics achieves large-scale manufacturing milestone	31/01	AQ
WuXi Biologics Launches WuXiaADCC PLUSTM for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect	26/01	AQ
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBodyTM	18/01	AQ
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates	12/01	AQ
WUXI BIOLOGICS TO PARTICIAPTE AT 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	10/01	AQ
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts	09/01	AQ
WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating	11/12	AQ
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of 6 g/L/day at Pilot Scale	23/11	AQ
Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics	21/11	AQ
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange	20/11	AQ
WuXi Biologics Cayman : Citi China Investor Conference 2023	06/11	PU
WuXi Biologics Receives the Asset ESG Corporate Platinum Award for Third Consecutive Year	01/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXWY

US98260N1081

Press Releases

Filters